Evidence map›Paper›PMID 33815555›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Platelet Distribution Width and Mortality in Hemodialysis Patients.

Wang Ruiyan, Xu Bin, Dong Jianhua, Zhou Lei, Gong Dehua, Zheng Tang

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Platelet indices and incident CKD in high-risk individuals.Clinical and experimental nephrology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wang RuiyanJinling Hospital Department of Nephrology, Nanjing Medical University, Nanjing, China.
Xu BinJinling Hospital Research Institute of Kidney Disease, Nanjing University School of Medicine, Nanjing, China.
Dong JianhuaJinling Hospital Research Institute of Kidney Disease, Nanjing University School of Medicine, Nanjing, China.
Zhou LeiJinling Hospital Research Institute of Kidney Disease, Nanjing University School of Medicine, Nanjing, China.
Gong DehuaJinling Hospital Research Institute of Kidney Disease, Nanjing University School of Medicine, Nanjing, China.ORCID https://orcid.org/0000-0003-0463-3393
Zheng TangJinling Hospital Department of Nephrology, Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe association between platelet distribution width (PDW) and mortality in hemodialysis (HD) patients has received little attention.

methodsWe retrospectively enrolled HD patients in a single center from January 1, 2008, to December 30, 2011. The primary and secondary endpoints were all-cause and cardiovascular mortality, respectively. The association between PDW and mortality was estimated by Cox regression model.

resultsOf 496 patients, the mean age was 52.5 ± 16.6 years, and the Charlson comorbidity index was 4.39 ± 1.71. During the follow-up period of 48.8 ± 6.7 months, 145 patients (29.2%) died, including 74 (14.9%) cardiovascular deaths. 258 (52.0%) with PDW < 16.31% were in the low group and 238 (48.0%) in those with PDW ≥ 16.31% according to cut-off for all-cause mortality by receiving-operator characteristics. After adjusting for confounding factors, high PDW values were independently associated with higher risk of all-cause (hazards ratio (HR) = 1.49, 95% confidence interval (CI) 1.15-6.82) and cardiovascular deaths (HR = 2.26, 95% CI 1.44-3.63) in HD patients. When comparing with quartile 1 of PDW, quartile 4 of PDW was independently associated with a higher risk of all-cause (HR = 1.59, 95% CI 1.18-5.30) and cardiovascular deaths (HR = 2.71, 95% CI 1.49-3.76) in HD patients.

conclusionsBaseline PDW was independently associated with all-cause and cardiovascular mortality in HD patients.

Identifiers

PMID33815555
PMCPMC7987410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.